Target a master regulator of cellular energetics with SLU-PP-332, a potent and selective agonist of the Estrogen-Related Receptor Alpha (ERRα). This nuclear receptor functions as a key transcriptional switch controlling genes involved in mitochondrial biogenesis, fatty acid β-oxidation, and oxidative phosphorylation. By specifically activating ERRα, SLU-PP-332 serves as a research tool to probe the consequences of enhancing this central pathway, which is fundamentally linked to cellular and systemic energy metabolism.
Supplied as a high-purity powder, SLU-PP-332 is designed for advanced preclinical research in metabolic diseases and mitochondrial biology. It is employed in studies investigating obesity, type 2 diabetes, and conditions characterized by mitochondrial dysfunction, where researchers aim to understand the potential of pharmacological ERRα activation to increase energy expenditure, improve metabolic flexibility, and influence body composition. Its selectivity makes it valuable for dissecting the specific role of ERRα apart from other related receptors.
Choosing SLU-PP-332 provides access to a targeted molecular tool for exploring the frontier of energy metabolism regulation. It enables foundational research into strategies that aim to optimize metabolic health by directly influencing the genetic programs that govern cellular power generation and fuel utilization.
